278 related articles for article (PubMed ID: 21507814)
1. Patient factors that influence warfarin dose response.
White PJ
J Pharm Pract; 2010 Jun; 23(3):194-204. PubMed ID: 21507814
[TBL] [Abstract][Full Text] [Related]
2. Warfarin therapy: evolving strategies in anticoagulation.
Horton JD; Bushwick BM
Am Fam Physician; 1999 Feb; 59(3):635-46. PubMed ID: 10029789
[TBL] [Abstract][Full Text] [Related]
3. Initiation of warfarin therapy in elderly medical inpatients: a safe and accurate regimen.
Siguret V; Gouin I; Debray M; Perret-Guillaume C; Boddaert J; Mahé I; Donval V; Seux ML; Romain-Pilotaz M; Gisselbrecht M; Verny M; Pautas E
Am J Med; 2005 Feb; 118(2):137-42. PubMed ID: 15694897
[TBL] [Abstract][Full Text] [Related]
4. Decreased INR response secondary to warfarin-flucloxacillin interaction.
Garg A; Mohammed M
Ann Pharmacother; 2009 Jul; 43(7):1374-5. PubMed ID: 19584391
[No Abstract] [Full Text] [Related]
5. Oral anticoagulation with warfarin is significantly influenced by steroids and CYP2C9 polymorphisms in children with cancer.
Ruud E; Holmstrøm H; Bergan S; Wesenberg F
Pediatr Blood Cancer; 2008 Mar; 50(3):710-3. PubMed ID: 17226852
[TBL] [Abstract][Full Text] [Related]
6. Influence of CYP2C9 polymorphisms, demographic factors and concomitant drug therapy on warfarin metabolism and maintenance dose.
Herman D; Locatelli I; Grabnar I; Peternel P; Stegnar M; Mrhar A; Breskvar K; Dolzan V
Pharmacogenomics J; 2005; 5(3):193-202. PubMed ID: 15824753
[TBL] [Abstract][Full Text] [Related]
7. Clinical factors influencing the sensitivity to warfarin when restarted after surgery.
Schulman S; El Bouazzaoui B; Eikelboom JW; Zondag M
J Intern Med; 2008 Apr; 263(4):412-9. PubMed ID: 18205763
[TBL] [Abstract][Full Text] [Related]
8. Optimal initial dose adjustment of warfarin in orthopedic patients.
Lenzini PA; Grice GR; Milligan PE; Gatchel SK; Deych E; Eby CS; Burnett RS; Clohisy JC; Barrack RL; Gage BF
Ann Pharmacother; 2007 Nov; 41(11):1798-804. PubMed ID: 17911206
[TBL] [Abstract][Full Text] [Related]
9. [Current issues in the initial phase of warfarin therapy].
Squizzato A; Steidl L; Ageno W
Recenti Prog Med; 2005 Dec; 96(12):612-5. PubMed ID: 16496748
[TBL] [Abstract][Full Text] [Related]
10. Initiating warfarin therapy: 5 mg versus 10 mg.
Eckhoff CD; Didomenico RJ; Shapiro NL
Ann Pharmacother; 2004 Dec; 38(12):2115-21. PubMed ID: 15522981
[TBL] [Abstract][Full Text] [Related]
11. Effect of heart failure exacerbations on anticoagulation: a prospective, observational, pilot cohort study.
Ripley TL; Harrison D; Germany RE; Adamson PB
Clin Ther; 2010 Mar; 32(3):506-14. PubMed ID: 20399987
[TBL] [Abstract][Full Text] [Related]
12. Increased warfarin doses and decreased international normalized ratio response after nationwide generic switching.
Halkin H; Shapiro J; Kurnik D; Loebstein R; Shalev V; Kokia E
Clin Pharmacol Ther; 2003 Sep; 74(3):215-21. PubMed ID: 12966365
[TBL] [Abstract][Full Text] [Related]
13. Tailoring warfarin induction doses to reflect individual and disease-specific factors.
Ageno W; Squizzato A; Dentali F; Crowther M
Am J Med; 2005 Feb; 118(2):143-4. PubMed ID: 15694898
[No Abstract] [Full Text] [Related]
14. [Use of warfarin and low range INR in the prevention of recurrent venous thrombosis].
Quintero J; Torres E; Diez-Ewald M; Arteaga-Vizcaíno M; Vizcaíno G; León M; Rodríguez Z; Fernández N
Invest Clin; 2011 Sep; 52(3):230-8. PubMed ID: 21950194
[TBL] [Abstract][Full Text] [Related]
15. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
16. [Interaction between warfarin and oral miconazole gel].
Ogard CG; Vestergaard H
Ugeskr Laeger; 2000 Oct; 162(41):5511. PubMed ID: 11068529
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenomics and warfarin therapy.
Ndegwa S
Issues Emerg Health Technol; 2007 Oct; (104):1-8. PubMed ID: 17912794
[TBL] [Abstract][Full Text] [Related]
18. Recurrent venous thrombosis despite 'optimal anticoagulation therapy' for antiphospholipid syndrome--could new oral anticoagulants solve the problem?
Balaban M; Stanrić V; Rincić G; Ledinsky M; Grbac L; Stancić N; Tomasić H
Acta Clin Croat; 2010 Dec; 49(4):469-77. PubMed ID: 21830460
[TBL] [Abstract][Full Text] [Related]
19. Chitosan potentiation of warfarin effect.
Huang SS; Sung SH; Chiang CE
Ann Pharmacother; 2007 Nov; 41(11):1912-4. PubMed ID: 17925502
[TBL] [Abstract][Full Text] [Related]
20. Probable drug interaction between warfarin and hormonal contraceptives.
Zingone MM; Guirguis AB; Airee A; Cobb D
Ann Pharmacother; 2009 Dec; 43(12):2096-102. PubMed ID: 19934391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]